Publications by authors named "C G Schuette"

Populations of Ozark hellbenders (Cryptobranchus alleganiensis bishopi, Grobman 1943) in Missouri and Arkansas are federally listed as endangered. The Saint Louis Zoo WildCare Institute's Ron and Karen Goellner Center for Hellbender Conservation, in collaboration with the Missouri Department of Conservation and US Fish and Wildlife Service, has developed a sustainable conservation breeding and head-starting program, a priority for species recovery. Using 9 years of program data, we examined various egg production, egg development, and mortality responses of Zoo-bred Ozark hellbenders.

View Article and Find Full Text PDF

Ozark hellbender (Cryptobranchus alleganiensis bishopi, Grobman 1943) populations in Missouri and Arkansas have been federally listed as endangered since 2011. As part of the comprehensive recovery plan for the subspecies, the Saint Louis Zoo WildCare Institute's Ron and Karen Goellner Center for Hellbender Conservation, in collaboration with the Missouri Department of Conservation, Arkansas Game and Fish Commission, and the U.S.

View Article and Find Full Text PDF

Digital media are becoming increasingly influential in society, especially among the younger generation. Therefore, an augmented reality (AR) app was developed that simulates experiments with radioactive sources. The app runs experiments on the range and penetration power of alpha, beta and gamma radiation.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the clinical success of a new cryoballoon (CB3) compared to an older version (CB2) for isolating pulmonary veins in patients with atrial fibrillation.
  • Both devices achieved high success rates in isolating pulmonary veins, with CB3 showing a 69.2% rate of real-time signal visualization compared to 54.8% for CB2.
  • Despite CB3's advantage in recording capabilities, both devices had similar outcomes in maintaining sinus rhythm after one year of follow-up.
View Article and Find Full Text PDF

Background: Although antiplatelet therapy involving clopidogrel is a standard treatment for preventing cardiovascular events after coronary stent implantation, patients can display differential responses. Here, we assessed the effectiveness of clopidogrel on platelet function inhibition in subjects with and without type-2 diabetes and stable coronary artery disease. In addition, we investigated the correlation between platelet function and routine clinical parameters.

View Article and Find Full Text PDF